| 标题 |
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Cornelia L. Trimble; Matthew P. Morrow; Kimberly A. Kraynyak; Xuefei Shen; Michael Dallas; et al 出版日期:2015-09-18 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)